224 results on '"L.S."'
Search Results
2. PCR135 Selecting Preference-Based Measures (PBMS) for Pediatric Studies: A Proposed Decision Making Framework
3. EPH223 Clinical, Economic, and Humanistic Burden of Atherosclerotic Cardiovascular Disease (ASCVD) and Familial Hypercholesterolemia (FH) in Latin America: A Scoping Review (SR)
4. PCR193 Health State Utilities Associated with X-Linked Retinitis Pigmentosa in the United Kingdom
5. PCR157 Assessment of Health State Utilities for Invasive Pneumococcal Disease, Pneumonia, and Acute Otitis Media in Young Children
6. Health Care Resource Use and Costs in Opioid-Treated Patients with and without Constipation in Brazil
7. PRO62 Qualitative Interviews to Assess the Content Validity of a Novel Raynaud Diary in Patients with Systemic Sclerosis
8. PRO62 Qualitative Interviews to Assess the Content Validity of a Novel Raynaud Diary in Patients with Systemic Sclerosis
9. EPH238 Head and Neck Squamous Cell Carcinoma Epidemiology at Diagnosis: A Description of Public and Private Health Care Systems in Brazil Regarding Tumor Location, Staging, Risk Factors and Mortality
10. CO187 The Framing of Time-Dependent Machine Learning Models Improves Risk Estimation Among Young Individuals with Acute Coronary Syndromes
11. SA50 Comparative Efficacy of Bimekizumab in Biologic/Targeted Synthetic DMARD-Naïve Patients with Axial Spondyloarthritis: Results from a Systematic Literature Review and Network Meta-Analysis
12. RWD136 Real-World Use of Biologic Disease-Modifying Anti-Rheumatic Drugs in US Patients with Ankylosing Spondylitis: Persistence, Factors Associated with Discontinuation, and Dosing Patterns
13. PCR109 Health State Utilities Associated with Weight Loss in People with Type 2 Diabetes in Japan
14. PCR38 Contextualizing Health-State Utilities in Patients with Transfusion-Dependent eta-Thalassemia (TDT)
15. PCN9 Effectiveness of Alectinib in a Real-World US Cohort
16. PDB83 Application of a Novel Algorithm to Identify Individuals with Possible Adult Growth Hormone Deficiency in the US: A Retrospective, Administrative Claims Database Study
17. PDB82 Development of a Novel Algorithm to Identify Individuals with Possible Adult Growth Hormone Deficiency from a US Administrative Claims Database
18. PDB82 Development of a Novel Algorithm to Identify Individuals with Possible Adult Growth Hormone Deficiency from a US Administrative Claims Database
19. PCV20 MACHINE LEARNING BETTER PREDICTS RISK AFTER ACUTE CORONARY SYNDROMES, IDENTIFIES HIGH-COST INDIVIDUALS AND THOSE WITH ELEVATED BURDEN OF UNCONTROLLED RISK FACTORS
20. PCN9 Effectiveness of Alectinib in a Real-World US Cohort
21. PDB83 Application of a Novel Algorithm to Identify Individuals with Possible Adult Growth Hormone Deficiency in the US: A Retrospective, Administrative Claims Database Study
22. PCV20 MACHINE LEARNING BETTER PREDICTS RISK AFTER ACUTE CORONARY SYNDROMES, IDENTIFIES HIGH-COST INDIVIDUALS AND THOSE WITH ELEVATED BURDEN OF UNCONTROLLED RISK FACTORS
23. PSU2 CTA VS. DSA FOR POST-CLIPPING ANEURYSM OBLITERATION DETECTION: A META-ANALYSIS
24. PND4 THE EFFECTIVENESS OF ANTIEPILEPTIC MEDICATIONS AS PROPHYLAXIS OF EARLY SEIZURE IN TRAUMATIC BRAIN INJURY PATIENTS COMPARED TO PLACEBO OR NO TREATMENT: A SYSTEMATIC REVIEW AND META-ANALYSIS
25. PDG78 SAFETY AND EFFICACY OF TRANEXAMIC ACID IN ADULT SPINAL DEFORMITY SURGERY: A META-ANALYSIS
26. PSU9 MINIMALLY INVASIVE VERSUS OPEN SURGERY FOR THE CORRECTION OF ADULT DEGENERATIVE SCOLIOSIS: A SYSTEMATIC REVIEW AND META-ANALYSIS
27. PRO2 MEDICAL THERAPY FOR CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION: AN INDIRECT TREATMENT COMPARISON OF MACITENTAN AND RIOCIGUAT
28. PND71 THE PREVALENCE OF COMPLICATIONS ASSOCIATED WITH SPINAL DEFORMITY SURGERY IN THE ELDERLY POPULATION: A META-ANALYSIS
29. PSU33 ADULT SPINAL DEFORMITY SURGERY: A SYSTEMATIC REVIEW OF VENOUS THROMBOPROPHYLAXIS AND INCIDENCE OF VENOUS THROMBOEMBOLIC EVENTS
30. PCN131 - ASSESSING THE REAL-WORLD COST OF CARE IN PATIENTS WITH METASTATIC TRIPLE NEGATIVE BREAST CANCER (MTNBC) IN THE UNITED STATES
31. PMD177 - PATIENT PREFERENCES AND HEALTH STATE UTILITIES ASSOCIATED WITH DULAGLUTIDE AND SEMAGLUTIDE INJECTION DEVICES AMONG PATIENTS WITH TYPE 2 DIABETES IN ITALY
32. PSY191 - HEALTH STATE UTILITIES ASSOCIATED WITH TREATMENT FOR TRANSFUSION DEPENDENT B-THALASSEMIA
33. PSY42 - EXPLORING THE POTENTIAL BUDGET IMPACT OF EMICIZUMAB FOR HEMOPHILIA A WITH INHIBITOR IN ITALY
34. PUK21 - COST UTILITY ANALYSIS OF END STAGE RENAL DISEASE TREATMENT IN MINISTRY OF HEALTH DIALYSIS CENTRES, MALAYSIA: HAEMODIALYSIS VERSUS CONTINUOUS AMBULATORY PERITONEAL DIALYSIS
35. PDB119 - PATIENT PREFERENCES AND HEALTH STATE UTILITIES ASSOCIATED WITH MEALTIME INSULIN CONCENTRATIONS AMONG PATIENTS WITH DIABETES IN ITALY
36. PSY95 - EXPLORING THE POTENTIAL COST-EFFECTIVENESS OF EMICIZUMAB FOR HEMOPHILIA A WITH INHIBITOR IN ITALY
37. In their own words: Social listening for 'Real-World Benefits' from prescription and OTC products
38. Expanding the Measurement of Treatment Benefit in Rheumatoid Arthritis: The Role of the Patient-Reported Outcome Consortium’s RA Working Group
39. SOCIAL MEDIA DATA SHOWS UTILITY FOR THE ASSESSMENT OF BENEFIT-RISK EARLY AFTER PRESCRIPTION TO OVER-THE-COUNTER SWITCH
40. BETTER EFFECTIVENESS OF HERPES ZOSTER VACCINE IN PREVENTING HERPES ZOSTER OPHTHALMICUS WITH OCULAR INVOLVEMENT
41. EARLY OPIOID USE, PATIENT-REPORTED OUTCOMES, AND UTILIZATION AMONG OLDER ADULTS WITH NEW EPISODES OF CARE FOR LOW BACK PAIN
42. PATIENT PERCEPTIONS OF NON-INSULIN INJECTION DEVICES FOR TYPE 2 DIABETES
43. Economic Evaluation of Axitinib for Second Line Treatment in Adult Patients with Advanced Renal Cell Carcinoma – the Portuguese Case
44. Antiepileptic Drug (AED) Treatment Sequencing in the Uk in Patients with Epilepsy: Real-Life Practice Data Using CPRD
45. The Association Of Dementia With Time To Hospitalizations: Is There A Need For Disease Management?
46. SOCIAL MEDIA DATA SHOWS UTILITY FOR THE ASSESSMENT OF BENEFIT-RISK EARLY AFTER PRESCRIPTION TO OVER-THE-COUNTER SWITCH
47. PCN156 Development and Validation of a Patient-Reported Questionnaire to Assess the Quality of Life Outcomes of Indian Breast Cancer Patients
48. PSY2 Adverse Event Burden, Resource Use and Costs Associated With Immunosuppressant Therapy for the Treatment of Systemic Lupus Erythematosus: A Systematic Literature Review
49. In their own words: Social listening for “Real-World Benefits” from prescription and OTC products
50. Contribution of Latin America to Mental Health in Pregnancy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.